Cubist Systematic Strategies, LLC Lava Therapeutics Nv Call Options Transaction History
Cubist Systematic Strategies, LLC
- $19.3 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LVTX
# of Institutions
24Shares Held
7.04MCall Options Held
149KPut Options Held
36.4K-
Shay Capital LLC New York, NY2.55MShares$4.23 Million0.44% of portfolio
-
Redmile Group, LLC San Francisco, CA2.07MShares$3.44 Million0.36% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.97MShares$3.27 Million2.81% of portfolio
-
Gts Securities LLC New York, NY200KShares$332,0000.01% of portfolio
-
Rangeley Capital, LLC New Canaan, CT165KShares$273,9000.22% of portfolio
About LAVA Therapeutics NV
- Ticker LVTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,797,700
- Market Cap $42.8M
- Description
- LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...